We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Check the tariff classification for flavour pods.
Substances that are classed as persistent organic pollutants (POPs) and when you're allowed to use them.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
How to use an interrupted time series to evaluate your digital health product.
Healthcare professionals prescribing montelukast should be alert to the risk of neuropsychiatric reactions in all patients including children and adolescents. Reported neuropsychiatric reactions include sleep disorders, hallucinations, anxiety and depression, as well as changes in behaviour and mood. Healthcare professionals...
The New Active Substance Work Sharing Initiative (NASWSI) has successfully approved several medicines through this international collaboration and continues to foster cooperation and strong relationships between its Access partners. The Biosimilar Work Sharing Initiative (BSWSI) builds on this success.
Advice and guidance on the health needs of migrant patients from Colombia for healthcare practitioners.
Check the tariff classification for vitamin gummies.
Advice and guidance on the health needs of migrant patients from Iran for healthcare practitioners.
Advice and guidance on the health needs of migrant patients from Uruguay for healthcare practitioners.
The surveillance, epidemiology, diagnosis and management of gonorrhoea (Neisseria gonorrhoeae).
Advice and guidance on the health needs of migrant patients from Bolivia for healthcare practitioners.
Advice and guidance on the health needs of migrant patients from Democratic Republic of Congo for healthcare practitioners.
Advice and guidance on the health needs of migrant patients from Venezuela for healthcare practitioners.
Get help to classify pharmaceutical products used to treat or prevent diseases or ailments (in humans or animals), including comparators used in clinical trials and placebos.
Information about when you need to submit substantial amendments to a clinical trial including changes to the trial sponsor or legal representative, Investigational medicinal product certification and importation.
Safety leaflet on topical corticosteroids and withdrawal reactions to help patients and their carers to use these medicines safely.
Further measures to be introduced to ensure patients who are prescribed montelukast for the treatment of asthma are informed of the risk of neuropsychiatric reactions
How to apply for marketing authorisation via this new procedure.
Guidance on how to license electronic cigarettes and other inhaled nicotine-containing products (NCPs) as medicines in the UK.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.